PTK7 and prostate carcinoma: In prostate cancer, higher PTK7 expression means more lymph node metastasis, later tumor stage, higher frequency of seminal vesicle invasion and angiolymphatic invasion, higher levels of preoperative PSA, higher risk of biochemical recurrence (94), and higher Gleason score (94, 95).